Biotech Coronavirus Covid-19 Healthcare Shanghai Technology
Researchers work in a lab of Shanghai-based 3DMed Diagnostics. [Photo provided to chinadaily.com.cn] Developed by a local biotech company, a testing kit that is able to screen individuals for both the novel coronavirus and the influenza virus at once was granted market approval by the National Medical Products Administration. The nucleic acid testing kit by 3DMed Diagnostics, a Shanghai-based medical testing solutions provider, is the first of its kind in the country to function based on fluorescence quantitative PCR platform, the Shanghai Science and Technology Commission said on Aug 19 following the product's market approval on Aug 16. Experts explained…
News Timeline:
Track the development of related news across the Internet.
October 17, 2025
03:25
Source: ChinaMoneyNetwork.com
June 3, 2025
02:36
Source: theglobeandmail.com
May 15, 2025
15:38
Source: indiatvnews.com
February 20, 2025
10:11
Source: theglobeandmail.com
February 19, 2025
17:35
Source: gizchina.com